CINECA IRIS Institutional Research Information System

CAPONNETTO, SALVATORE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 720
SA - Sud America 348
NA - Nord America 236
EU - Europa 95
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.413
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 271
US - Stati Uniti d'America 196
SG - Singapore 177
VN - Vietnam 153
HK - Hong Kong 132
CN - Cina 121
IT - Italia 50
KR - Corea 48
BD - Bangladesh 42
AR - Argentina 35
MX - Messico 26
FR - Francia 19
EC - Ecuador 17
ID - Indonesia 13
IN - India 12
DE - Germania 7
CL - Cile 6
CO - Colombia 6
IQ - Iraq 5
RU - Federazione Russa 5
MA - Marocco 4
PE - Perù 4
PL - Polonia 4
PY - Paraguay 4
VE - Venezuela 4
CA - Canada 3
DZ - Algeria 3
GB - Regno Unito 3
JM - Giamaica 3
PK - Pakistan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EG - Egitto 2
SV - El Salvador 2
TN - Tunisia 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ES - Italia 1
FI - Finlandia 1
JO - Giordania 1
JP - Giappone 1
KZ - Kazakistan 1
NI - Nicaragua 1
NL - Olanda 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UA - Ucraina 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 1.413
Salva come PNG Salva come JPEG
Città #
Hong Kong 131
Ho Chi Minh City 67
San Jose 54
Seoul 47
Singapore 40
Ashburn 35
Beijing 35
Hanoi 23
Mexico City 17
São Paulo 17
New York 15
Da Nang 8
Buffalo 6
Chicago 6
Haiphong 6
Milan 6
Orem 6
Quito 6
Biên Hòa 5
Campinas 5
Guayaquil 5
Porto Alegre 5
Belo Horizonte 4
Buenos Aires 4
Dallas 4
Juiz de Fora 4
Naples 4
Niterói 4
Reston 4
Rome 4
Santa Clara 4
Santiago 4
Thái Bình 4
Asunción 3
Barretos 3
Brasília 3
Bình Dương 3
Bắc Giang 3
Caxias do Sul 3
Curitiba 3
Fortaleza 3
Frankfurt am Main 3
Hillsboro 3
Kingston 3
Los Angeles 3
Mauá 3
Rio de Janeiro 3
Roubaix 3
Santo Domingo de los Colorados 3
Uberlândia 3
Warsaw 3
Barbacena 2
Barueri 2
Batam 2
Bauru 2
Bogotá 2
Brooklyn 2
Campina Grande 2
Cesena 2
Concordia 2
Contagem 2
Cruz Alta 2
Cruz das Almas 2
Cuiabá 2
Currais Novos 2
Dhaka 2
Dubai 2
Duque de Caxias 2
Esmeraldas 2
Gravataí 2
Guadalajara 2
Houston 2
Hưng Yên 2
Hải Dương 2
Itabira 2
Jakarta 2
Lima 2
Londrina 2
Manaus 2
Manchester 2
Mumbai 2
Novo Hamburgo 2
Osasco 2
Pelotas 2
Pindamonhangaba 2
Piracicaba 2
Queens 2
Ribeirão Preto 2
Rio Grande 2
Salvador 2
San Juan 2
San Salvador 2
Santo Domingo 2
Santos 2
Sorocaba 2
São José do Rio Preto 2
São José dos Campos 2
Tashkent 2
Toronto 2
Viamão 2
Totale 741
Salva come PNG Salva come JPEG
Nome #
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors 57
Impact of sarcopenia and inflammation on patients with advanced non-small cell lung cancer (Ncscl) treated with immune checkpoint inhibitors (icis): a prospective study 53
RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study 46
Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients 46
Efficacy and tolerability of selective internal radiotherapy with Yttrium-90 as consolidation treatment after chemotherapy in metastatic colorectal cancer 44
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer 43
Prognostic value of the BIO-Ra Score in metastatic castration-resistant prostate cancer patients treated with Radium-223 after the European Medicines Agency restricted use: secondary investigations of the multicentric BIO-Ra study 40
Adjuvant chemotherapy in resected colon cancer: when, how and how long? 40
Identification of Poliovirus Receptor-like 3 Protein as a Prognostic Factor in Triple-Negative Breast Cancer 40
Circulating methylated dna to monitor the dynamics of ras mutation clearance in plasma from metastatic colorectal cancer patients 39
First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review 39
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer 38
About RAS Mutation Clearance in Plasma ctDNA From RAS-Mutant Colorectal Cancer Patients 35
Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer 35
Prognostic and predictive role of body mass index (BMI) in metastatic colorectal cancer (mCRC): a pooled analisys of tribe and tribe-2 studies by GONO 35
Tumor associated MUC1 carried by microvesicles is cross-processed by dendritic cells generating CD8+ T cell response 35
Lenvatinib Versus Sorafenib in Advanced Hepatic Cell Carcinoma: A Double Center Retrospective Analysis 34
Preliminary efficacy and safety data of nivolumab in never smoker patients with advanced squamous NSCLC: Experience from Italian sites participating in the Expanded Access Programme (EAP) 34
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse 33
Evaluation of efficacy of ALK inhibitors according to body mass index in ALK rearranged NSCLC patients—A retrospective observational study 33
Burned-out testicular cancer: really a different history? 33
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab 32
Cancer immunotherapy in patients with brain metastases 31
Immunological and clinical impact of cancer stem cells in vulvar cancer: role of CD133/CD24/ABCG2-Expressing Cells 31
P-158Radioembolization (SIRT) as a Consolidation Treatment in Colorectal Liver Metastases after First Line Chemotherapy: Efficacy Safety 30
A Comparison Between First-, Second- and Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small-Cell Lung Cancer and Brain Metastases 30
Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence 29
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse 29
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab 29
Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer 28
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO 28
True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature 28
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study 27
In vitro and in vivo anticancer action of saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells 27
Merkel cell carcinoma of the retroperitoneum with no identifiable primary site 27
The value of the multidisciplinary team in metastatic renal cell carcinoma: paving the way for precision medicine in toxicities management 25
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: clinical and immunological data of a phase I/II clinical trial 25
Prolactin as a potential early predictive factor in metastatic non-small cell lung cancer patients treated with Nivolumab 25
Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor 24
Why the therapeutic impact of RAS mutation clearance in plasma ctDNA deserves to be further explored in metastatic colorectal cancer 24
Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor 24
TK inhibitor pazopanib primes DCs by downregulation of the β-catenin pathway 22
The macrophage Galactose-type C-type Lectin (MGL) modulates regulatory T cell functions 22
MGL receptor and immunity: when the ligand can make the difference 18
Intensified Total Neoadjuvant Therapy Versus Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching Analysis 11
Totale 1.458
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.812
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.812
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202544 0 0 0 0 0 0 1 1 4 20 5 13
2025/20261.414 177 20 229 355 116 72 36 81 131 72 94 31
Totale 1.458